Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARC1507 in Advanced Biliary Tract Cancer
NCT02597465Phase 3Withdrawn
- Sponsor
- Sun Pharma
- Start
- Dec 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of SPARC-1507 in biliary tract cancer (BTC), sponsored by Sun Pharma. Planned start Dec 2018; status: withdrawn.
02
Drugs
SPARC-1507
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT02597465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597465.